James Investment Research’s Steris STE Stock Holding History

James Investment Research’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15	Closed	-$3K	–	545
2022 Q2	$3K	Buy	+15	New	+$3.38K	﹤0.01%	473

Other funds holding STE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

James Investment Research's STE Position: Q3 2022 in Review

James Investment Research sold out of Steris (STE) in Q3 2022, closing a stake of 15 shares — an estimated $3K sold.

James Investment Research first reported a position in STE in Q2 2022 and held it in 1 quarter. The position peaked at $3K in Q2 2022. 637 funds tracked by Wall St. Rank hold STE as of Q3 2022.

James Investment Research reported no remaining Steris position as of Q3 2022 after selling out during the quarter.
James Investment Research sold 15 Steris shares in Q3 2022, an estimated $3K.
James Investment Research first reported a position in Steris in Q2 2022 and held it in 1 quarter.
James Investment Research's Steris position peaked at $3K in Q2 2022.
637 funds tracked by Wall St. Rank held Steris as of Q3 2022.

Based on James Investment Research's 13F filing for Q3 2022, filed 31 Oct 2022.